Skip to content
Search

Latest Stories

Submit Guest Post

Bangladesh imposes lockdown in Rohingya camps

Bangladesh has imposed a lockdown on a southern district, home to refugee camps housing more than a million Rohingya Muslims fleeing from Myanmar, to prevent the spread of coronavirus.

Officials said no-one was allowed to enter or exit Cox's Bazar district.


Cox's Bazar district head Kamal Hossain announced the measures following a rise in cases in the country as a whole.

The number of infections in Bangladesh has doubled to more than 200 in the last five days, with 20 dead.

"Entry and exit from Cox's Bazar district is prohibited from now on," Mr Hossain said in a statement, adding that "stern action" would be taken against those who violated the order.

"Only emergency food supply and medical services can continue work in the camps by maintaining extreme caution," Refugee Commissioner Mahbub Alam Talukder said.

Anyone who had arrived in the country recently would have to go into quarantine before visiting the camps, he added.

No cases are confirmed in the camps, but aid agencies fear an outbreak could overwhelm poor medical facilities.

Most refugees arrived in the camps following a military crackdown in the neighbouring state in 2017.

Almost 750,000 crossed the border, joining hundreds of thousands of refugees already living there.

Last week Human Rights Watch warned that 350,000 people within Myanmar itself were especially vulnerable to coronavirus.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

cancer treatment

The NHS availability announced in September 2026 applies to eligible patients in England. The treatment has already been available in Scotland for more than two years.

What is Enhertu and how could the new NHS breast cancer treatment help patients?

Highlights:
  • Enhertu is a targeted treatment for certain HER2-low breast cancers.
  • It is available for around 1,000 women in England.
  • The drug can extend survival compared with chemotherapy.
  • NICE initially rejected widespread NHS use in 2024.
  • The decision was reversed after a commercial agreement was reached.

Breast cancer treatment continues to evolve as researchers develop therapies aimed at specific characteristics of cancer cells. One such treatment is Enhertu, which has now become available on the NHS in England for people with a particular type of advanced breast cancer.

The treatment is intended for patients with HER2-low breast cancer that cannot be removed through surgery or has spread to other parts of the body. This is known as metastatic breast cancer. According to the latest announcement, around 1,000 women in England will be eligible for the treatment.

Keep ReadingShow less